Kohjin Bio Co., Ltd.
Kohjin Bio Co., Ltd.
Acción · JP3283630006 (XTKS)
Resumen
Sin cotización
Precio de cierre XTKS 05.11.2025: 1.516,00 JPY
05.11.2025 01:11
Cotizaciones actuales de Kohjin Bio Co., Ltd.
BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XTKS: Tokyo
Tokyo
177A.T
JPY
05.11.2025 01:11
1.516,00 JPY
-8,00 JPY
-0,52 %
Flotación y Liquidez de las Acciones
Flotación Libre 28,76 %
Acciones en Flotación 1,47 M
Acciones en Circulación 5,11 M
Perfil de la empresa para Kohjin Bio Co., Ltd. Acción
Kohjin Bio Co., Ltd. manufactures and sells animal blood, sera, tissue culture media, agar media for microorganism tests, in-vitro diagnostic agents, and cosmetics. The company offers tissue culture mediums for virus and recombinant protein production, hybridoma, human lymphocyte culture, and insect cell lines; gas permeable cell culture bags and other materials; cryopreservation agent of cells; medium supplements; normal human cells; normal human cell mediums; ES cell mediums; in-vitro fertilization and early embryo culture kits; and other culture and related products, such as supplements, cell separation solutions, physiological salt solutions, and research reagents. The company also offers clinical microbiology culture mediums for gram positive cocci, gram negative bacteria, and susceptibility testing; general differential, anaerobic growth, and fungal mediums; tube mediums for confirmation and expansion; microbiology culture mediums for food, such as mediums for sterilization test, E. coli and coliform bacteria, staphylococcus spp., bacillus cereus, and vibrio parahaemolyticus; culture mediums for determining total viable cell count; and campylobacter and fungal mediums. In addition, the company offers normal human blood, serum, and plasma; pathological human serum; preserved animal blood; defibrinated and hemolyzed animal blood; animal serum and plasma; and other custom-designed products, such as eagle medium. Further, the company engages in the production and sale of laboratory animal, sale of medical equipment, trust of animal immunization and antibody preparation, and import and export of products and raw materials. The company was formerly known as Kohjin Co.,Ltd and changed its name to Kohjin Bio Co., Ltd. in 1989. The company was incorporated in 1981 and is based in Sakado, Japan.
Obtén información actualizada de finAgent sobre Kohjin Bio Co., Ltd.

Datos de la empresa

Nombre Kohjin Bio Co., Ltd.
Empresa Kohjin Bio Co., Ltd.
Sitio web https://www.kohjin-bio.jp
Mercado principal XTKS Tokyo
ISIN JP3283630006
Tipo de valor Acción
Sector Healthcare
Industria Biotechnology
CEO Takahito Nakamura
Capitalización de mercado 8 Mrd.
País Japón
Moneda JPY
Empleados 0,2 T
Dirección 5-1-3, 350-0214 Sakado
Fecha de OPV 2024-04-25

Símbolos de cotización

Nombre Símbolo
Tokyo 177A.T
Otras acciones
Los inversores que tienen Kohjin Bio Co., Ltd. también tienen las siguientes acciones en su cartera:
Hybio Pharmaceutical Co., Ltd.
Hybio Pharmaceutical Co., Ltd. Acción
KROGER CO 12/22
KROGER CO 12/22 Bono
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025